190 related articles for article (PubMed ID: 21801465)
1. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
Leung YH; Lim WL; Wong MH; Chuang SK
Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
[TBL] [Abstract][Full Text] [Related]
2. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
[TBL] [Abstract][Full Text] [Related]
3. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
[TBL] [Abstract][Full Text] [Related]
4. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
7. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
[TBL] [Abstract][Full Text] [Related]
8. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
[TBL] [Abstract][Full Text] [Related]
9. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009.
Bhattarai A; Villanueva J; Palekar RS; Fagan R; Sessions W; Winter J; Berman L; Lute J; Leap R; Marchbanks T; Sodha SV; Moll M; Xu X; Fry A; Fiore A; Ostroff S; Swerdlow DL;
Clin Infect Dis; 2011 Jan; 52 Suppl 1():S102-8. PubMed ID: 21342880
[TBL] [Abstract][Full Text] [Related]
10. Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.
Malato L; Llavador V; Marmier E; Youssef J; Balick Weber C; Rozé H; Bessede E; Fleury HJ
Euro Surveill; 2011 Jan; 16(4):. PubMed ID: 21284922
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
12. [The significance of different sample types in study of pandemic A (H1N1) influenza diagnosis].
Huang F; Shi WX; Lu GL; Cui SJ; Lü YN; Tian LL; Qian HK; Yang P; Wang QY; Pang XH
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Dec; 44(12):1079-82. PubMed ID: 21215107
[TBL] [Abstract][Full Text] [Related]
13. Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.
Antón A; López-Iglesias AA; Tórtola T; Ruiz-Camps I; Abrisqueta P; Llopart L; Marcos MÁ; Martínez MJ; Tudó G; Bosch F; Pahissa A; de Anta MT; Pumarola T
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):214-9. PubMed ID: 20955912
[TBL] [Abstract][Full Text] [Related]
14. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
[TBL] [Abstract][Full Text] [Related]
15. Viral shedding in Chinese young adults with mild 2009 H1N1 influenza.
Jia N; Gao Y; Suo JJ; Xie LJ; Yan ZQ; Xing YB; He L; Liu YX
Chin Med J (Engl); 2011 May; 124(10):1576-9. PubMed ID: 21740820
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir overuse at a Chicago hospital during the 2009 influenza pandemic and the poor predictive value of influenza-like illness criteria.
Aziz M; Vasoo S; Aziz Z; Patel S; Eltoukhy N; Singh K
Scand J Infect Dis; 2012 Apr; 44(4):306-11. PubMed ID: 22026440
[TBL] [Abstract][Full Text] [Related]
17. Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients.
Giannella M; Alonso M; Garcia de Viedma D; Lopez Roa P; Catalán P; Padilla B; Muñoz P; Bouza E
Clin Microbiol Infect; 2011 Aug; 17(8):1160-5. PubMed ID: 20946412
[TBL] [Abstract][Full Text] [Related]
18. Benign clinical course in H1N1 2009 influenza infection in young oseltamivir-treated immunocompromised patients with kidney disease in Singapore.
Ng KH; Quak ZX; Chan YH; Suhaila M; Lau PY; Tambyah PA; Tang JW; Yap HK
Pediatr Infect Dis J; 2013 Mar; 32(3):298-300. PubMed ID: 23249911
[TBL] [Abstract][Full Text] [Related]
19. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
[TBL] [Abstract][Full Text] [Related]
20. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.
Sugaya N; Shinjoh M; Mitamura K; Takahashi T
J Infect; 2011 Oct; 63(4):288-94. PubMed ID: 21722665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
